These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10094460)

  • 21. Metabolic features of Johannesburg Bantu with myocardial infarction.
    Seftel HC; Spitz IM; Bersohn I; Goldin AR; Joffe BI; Rubenstein AH; Metzger BE
    S Afr Med J; 1973 Sep; 47(35):1571-5. PubMed ID: 4734030
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of C-peptide during the oral glucose tolerance test in obese children].
    Mazzanti L; Salardi S; Villa MP; Ventura D; Colaiuda B; Cocchi V; Capelli M; Tomesani A
    Minerva Pediatr; 1981 Apr; 33(7):309-15. PubMed ID: 7017376
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood insulin levels during oral glucose administration in 43 obese children].
    Vague P; Pierron H; Rouvier-Leroy C; Jaquet P; Vague J
    Ann Endocrinol (Paris); 1969; 30(4):556-69. PubMed ID: 5366870
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood glucose, insulin, and free fatty acid levels during oral glucose tolerance tests in 158 obese children.
    Deschamps I; Giron BJ; Lestradet H
    Diabetes; 1977 Feb; 26(2):89-93. PubMed ID: 838167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the relationship between obesity and hyperinsulinemia: Role of insulin secretion and insulin clearance.
    Kim MK; Reaven GM; Kim SH
    Obesity (Silver Spring); 2017 Feb; 25(2):378-383. PubMed ID: 28000428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian metabolic rhythms in obese children.
    Desjeux JF; Gernez-Lestradet C; Deschamps I; Machinot S; Rolland F; Lestradet H
    Ann Nutr Metab; 1982; 26(2):106-10. PubMed ID: 7044263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans.
    Maurer L; Brachs S; Decker AM; Brachs M; Leupelt V; Jumpertz von Schwartzenberg R; Ernert A; Bobbert T; Krude H; Spranger J; Mai K
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4014-4020. PubMed ID: 27459526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enterogenous hyperinsulinism in pernicious anemia].
    Hippe E; Rehfeld J
    Nord Med; 1970 Dec; 84(49):1571. PubMed ID: 5488580
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance in genetically obese, hyperglycemic mice.
    Genuth SM; Przybylski RJ; Rosenberg DM
    Endocrinology; 1971 May; 88(5):1230-8. PubMed ID: 5278387
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasmatic levels of insulin, high glucose and nefa in obese children (author's transl)].
    del Valle Núñez J; Cintado C; García Guerrero M; Ortega JL; Gayoso Gómez F
    An Esp Pediatr; 1974; 7(6):551-61. PubMed ID: 4458580
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
    Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
    Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
    Alemzadeh R; Langley G; Upchurch L; Smith P; Slonim AE
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
    Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic disturbance in obese children: glucose, insulin levels and lipid profile.
    Hwang HK; Chen MR; Lee YJ; Lee HC; Huang CY; Kao HA; Huang FY; Shih BF
    Acta Paediatr Taiwan; 2001; 42(2):75-80. PubMed ID: 11355068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between plasma insulin and angiographically documented significant coronary artery disease.
    Spallarossa P; Cordera R; Andraghetti G; Bertero G; Brunelli C; Caponnetto S
    Am J Cardiol; 1994 Jul; 74(2):177-9. PubMed ID: 8023786
    [No Abstract]   [Full Text] [Related]  

  • 40. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.